Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sulfatase modifying factor 2 (SUMF2) is a protein encoded in humans by the SUMF2 gene. SUMF2 is a member of the sulfatase-modifying factor family and encodes a protein localized to the endoplasmic reticulum lumen, characterized by a DUF323 domain. Although highly homologous to sulfatase modifying factor 1 (SUMF1), SUMF2 lacks catalytic formylglycine-generating activity and is unable to convert newly synthesized inactive sulfatases into their active forms. Instead, SUMF2 is thought to act as a regulatory protein: it heterodimerizes with SUMF1 and can inhibit SUMF1’s activation of sulfatases, suggesting a modulatory role in sulfatase enzyme activity and the regulation of post-translational modifications essential for sulfatase function[1][2][3][4][5][6]. SUMF2’s physiological relevance is demonstrated by its widespread tissue expression and its proposed involvement in the regulation of sulphatase activity, which is critical for cellular metabolism of sulfated molecules. SUMF2 does not have established direct disease-causing mutations, but altered regulation of sulfatases via SUMF2 may influence diseases linked to sulfatase deficiency[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sulfatase modifying factor 2 (SUMF2).